MRNA vaccine: Difference between revisions
Content deleted Content added
Clarified that RNA does not get taken up by cells spontaneously (that would make the life of viruses very easy) Tags: Visual edit Mobile edit Mobile web edit |
|||
| Line 1: | Line 1: | ||
{{More citations needed|date=February 2020}} |
{{More citations needed|date=February 2020}} |
||
An '''RNA vaccine''' is a type of vaccine which is composed of the nucleic acid RNA. Just like normal vaccines, RNA vaccines are intended to induce the production of antibodies which will bind to potential pathogens. |
An '''RNA vaccine''' is a type of vaccine which is composed of the nucleic acid RNA, packaged within a [[Expression vector|vector]] such as lipid nanoparticles<ref>{{Cite web|url=http://https/%3A%2F%2Fwww.curevac.com%2Fmrna-platform|title=mRNA Platform|website=CureVac|access-date=2020-03-21}}</ref>. Just like normal vaccines, RNA vaccines are intended to induce the production of antibodies which will bind to potential pathogens. This is accomplished when cells in the body take up the RNA from the vaccine and produce proteins that mimic proteins from the pathogen. These mimic proteins are used by the immune system to produce antibodies against the pathogen, causing future protection from the pathogen. <ref>{{cite web |last1=Hubaud |first1=Alexis |title=RNA vaccines: a novel technology to prevent and treat disease |url=http://sitn.hms.harvard.edu/flash/2015/rna-vaccines-a-novel-technology-to-prevent-and-treat-disease/ |website=sitn.hms.harvard.edu |publisher=Harvard University |accessdate=17 February 2020}}</ref> |
||
==See also== |
==See also== |
||
Revision as of 03:22, 21 March 2020
 | This article needs additional citations for verification. (February 2020) |
An RNA vaccine is a type of vaccine which is composed of the nucleic acid RNA, packaged within a vector such as lipid nanoparticles[1]. Just like normal vaccines, RNA vaccines are intended to induce the production of antibodies which will bind to potential pathogens. This is accomplished when cells in the body take up the RNA from the vaccine and produce proteins that mimic proteins from the pathogen. These mimic proteins are used by the immune system to produce antibodies against the pathogen, causing future protection from the pathogen. [2]
See also
References
- ^ "mRNA Platform". CureVac. Retrieved 2020-03-21.
{{cite web}}: Check|url=value (help) - ^ Hubaud, Alexis. "RNA vaccines: a novel technology to prevent and treat disease". sitn.hms.harvard.edu. Harvard University. Retrieved 17 February 2020.